Kolexia
Ternisien Catherine
Biologie médicale
Hôpital Hôtel-Dieu Nantes
Nantes, France
118 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hémophilie A Maladies de von Willebrand Hémorragie Thrombopénie Thrombose Maladie de von Willebrand de type 2 Syndrome des anticorps antiphospholipides Angiodysplasie Hémophilie B

Industries

Bayer
15 collaboration(s)
Dernière en 2023
Roche
10 collaboration(s)
Dernière en 2022
LFB
7 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
6 collaboration(s)
Dernière en 2022

Dernières activités

Key Drivers of Coagulation Factor Use in Von Willebrand Disease During Hospitalization: An Overview of the French BERHLINGO Cohort.
Clinical drug investigation   30 novembre 2023
Efficacy and safety of turoctocog alfa in patients with hemophilia A requiring surgical procedures: A multicentre retrospective study.
Transfusion   18 octobre 2023
Questions around a case of thrombosis in a premature child, concerning the management of anticoagulant treatments.
European journal of hospital pharmacy : science and practice   29 septembre 2023
Prothrombin consumption as an indicator of hemorrhagic phenotype in mild platelet function disorders.
European journal of haematology   08 août 2023
Hémophilie
HAS Publications   20 juin 2023
C-reactive protein and D-dimer in cerebral vein thrombosis: Relation to clinical and imaging characteristics as well as outcomes in a French cohort study.
Research and practice in thrombosis and haemostasis   28 mars 2023
A nanobody against the VWF A3 domain detects ADAMTS13-induced proteolysis in congenital and acquired VWD.
Blood   27 mars 2023
Biological, clinical features and modelling of heterozygous variants of glycoprotein Ib platelet subunit alpha (GP1BA) and glycoprotein Ib platelet subunit beta (GP1BB) genes responsible for constitutional thrombocytopenia.
British journal of haematology   29 septembre 2022
Monitoring the activity of direct oral anticoagulants in a patient with severe nephrotic syndrome and pulmonary embolism. Lessons for the clinical nephrologist.
Journal of nephrology   05 août 2022
Erratum: Effect of DDAVP on Platelet Activation and Platelet-Derived Microparticle Generation.
Hamostaseologie   30 juin 2022